PT99864A - Processo para a preparacao de novas composicoes farmaceuticas contendo antagonistas de receptor de quisqualato - Google Patents

Processo para a preparacao de novas composicoes farmaceuticas contendo antagonistas de receptor de quisqualato

Info

Publication number
PT99864A
PT99864A PT99864A PT9986491A PT99864A PT 99864 A PT99864 A PT 99864A PT 99864 A PT99864 A PT 99864A PT 9986491 A PT9986491 A PT 9986491A PT 99864 A PT99864 A PT 99864A
Authority
PT
Portugal
Prior art keywords
pharmaceutical compositions
compositions containing
receptor antagonists
new pharmaceutical
preparing new
Prior art date
Application number
PT99864A
Other languages
English (en)
Other versions
PT99864B (pt
Inventor
Helmut Dr Wachtel
Peter-Andreas Loeschmann
Lechoslaw Dr Turski
Thomas Klockgether
David Norman Dr Stephens
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE19904041981 external-priority patent/DE4041981A1/de
Priority claimed from DE19914121483 external-priority patent/DE4121483A1/de
Application filed by Schering Ag filed Critical Schering Ag
Publication of PT99864A publication Critical patent/PT99864A/pt
Publication of PT99864B publication Critical patent/PT99864B/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • A61K31/17Amides, e.g. hydroxamic acids having the group >N—C(O)—N< or >N—C(S)—N<, e.g. urea, thiourea, carmustine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/195Carboxylic acids, e.g. valproic acid having an amino group
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
PT99864A 1990-12-21 1991-12-19 Processo para a preparacao de novas composicoes farmaceuticas contendo antagonistas de receptor de quisqualato PT99864B (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19904041981 DE4041981A1 (de) 1990-12-21 1990-12-21 Neue verwendung von quisqualat-rezeptor-antagonisten
DE19914121483 DE4121483A1 (de) 1991-06-26 1991-06-26 Neue verwendung von quisqualat-rezeptor-antagonisten

Publications (2)

Publication Number Publication Date
PT99864A true PT99864A (pt) 1992-12-31
PT99864B PT99864B (pt) 1999-06-30

Family

ID=25899840

Family Applications (1)

Application Number Title Priority Date Filing Date
PT99864A PT99864B (pt) 1990-12-21 1991-12-19 Processo para a preparacao de novas composicoes farmaceuticas contendo antagonistas de receptor de quisqualato

Country Status (12)

Country Link
US (1) US6191132B1 (pt)
EP (1) EP0516795B1 (pt)
JP (1) JPH05505830A (pt)
AT (1) ATE180405T1 (pt)
AU (1) AU655958B2 (pt)
CA (1) CA2076524A1 (pt)
DE (1) DE59109130D1 (pt)
HU (1) HUT61467A (pt)
IE (1) IE914526A1 (pt)
IL (1) IL100458A (pt)
PT (1) PT99864B (pt)
WO (1) WO1992011012A1 (pt)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2313714T3 (es) * 1992-06-22 2009-03-01 The Regents Of The University Of California Antagonistas de receptores de glicina y uso de los mismos.
US5631373A (en) * 1993-11-05 1997-05-20 State Of Oregon, Acting By And Through The Oregon State Board Of Higher Education, Acting For And On Behalf Of The Oregon Health Sciences University And The University Of Oregon, Eugene Oregon Alkyl, azido, alkoxy, and fluoro-substituted and fused quinoxalinediones
US5922715A (en) * 1997-02-18 1999-07-13 American Home Products Corporation 5-aminoalkoxy-1, 4-dihydroquinoxaline-2, 3-diones
CN1248249A (zh) * 1997-02-18 2000-03-22 美国家用产品公司 多巴胺激动剂5-氨基烷氧基-1,4-二氢喹喔啉-2,3-二酮类化合物
DE10066158B4 (de) * 2000-08-24 2007-08-09 Neurobiotec Gmbh Verwendung eines transdermalen therapeutischen Systems zur Behandlung des Restless-Legs-Syndroms
DE10053397A1 (de) * 2000-10-20 2002-05-02 Schering Ag Verwendung eines dopaminergen Wirkstoffes zur Behandlung von dopaminerg behandelbaren Erkrankungen
DE10064453A1 (de) * 2000-12-16 2002-07-04 Schering Ag Verwendung eines dopaminergen Wirkstoffes zur Behandlung von dopaminerg behandelbaren Erkrankungen
WO2004110255A2 (en) 2003-06-09 2004-12-23 Gang Zheng Antineoplastic agents targeted via glut transporters
US20090030017A1 (en) * 2005-04-08 2009-01-29 Eisai R & D Management Co., Ltd Therapeutic agent for dyskinesia
WO2009054544A1 (en) * 2007-10-26 2009-04-30 Eisai R & D Management Co., Ltd. Ampa receptor antagonists for parkinson's disease and movement disorders
EP2338492A1 (en) * 2009-12-24 2011-06-29 Universidad del Pais Vasco Methods and compositions for the treatment of alzheimer

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5852219A (ja) * 1981-09-22 1983-03-28 Sumitomo Chem Co Ltd パ−キンソン病治療剤
IE66149B1 (en) * 1986-09-16 1995-12-13 Novo Nordisk As Quinoxaline compounds and their preparation and use
US4812458A (en) * 1986-09-16 1989-03-14 A/S Ferrosan 6,7-disubstituted-2,3-dihydroxyquinoxaline compounds, pharmaceutical compositions thereof, and their use as neuroleptics
DK146787A (da) * 1987-03-23 1988-09-24 Ferrosan Heterocykliske forbindelser, deres fremstilling og anvendelse
NO179551C (no) 1987-11-10 1996-10-30 Novo Nordisk As Analogifremgangsmåte for fremstilling av terapeutisk virksomme kinoxalinforbindelser
DK160941C (da) 1988-06-28 1991-10-21 Novo Nordisk As Kondenserede 2,3-dihydroxypyraziner, fremgangsmaade til deres fremstilling og farmaceutiske praeparater, hvori forbindelserne indgaar
DK338789A (da) * 1988-07-15 1990-01-16 Schering Ag 2-substituerede ergolinylurinstofderivater og fremgangsmaade til fremstilling deraf, deres anvendelse som laegemidler samt mellemprodukter til fremstilling deraf
DK715888D0 (da) 1988-12-22 1988-12-22 Ferrosan As Quinoxalinforbindelser, deres fremstilling og anvendelse
US4975430A (en) * 1989-06-16 1990-12-04 The State Of Oregon Acting By And Through The State Board Of Education On Behalf Of The Oregon Health Sciences University CNQX and its analogs as therapeutics for degenerative neural diseases

Also Published As

Publication number Publication date
AU655958B2 (en) 1995-01-19
IL100458A0 (en) 1992-09-06
DE59109130D1 (de) 1999-07-01
JPH05505830A (ja) 1993-08-26
HUT61467A (en) 1993-01-28
CA2076524A1 (en) 1992-06-21
PT99864B (pt) 1999-06-30
ATE180405T1 (de) 1999-06-15
HU9202990D0 (en) 1992-12-28
US6191132B1 (en) 2001-02-20
EP0516795B1 (de) 1999-05-26
IE914526A1 (en) 1992-07-01
EP0516795A1 (de) 1992-12-09
WO1992011012A1 (de) 1992-07-09
IL100458A (en) 1996-12-05
AU9139791A (en) 1992-07-22

Similar Documents

Publication Publication Date Title
MX9801305A (es) Composicion de disolucion rapida oral para agonistas de dopamina.
ATE175114T1 (de) Pharmazeutische zusammensetzungen enthaltend einen opiat antagonist und calcium salze, ihre verwendung zur behandlung von endorphin- vermittelten krankheiten
SE0104334D0 (sv) Therapeutic agents
NL970006I1 (nl) Gebruik van indolon-derivaten voor het bereiden van geneesmiddelen ter behandeling van de ziekte vanParkinson.
SE8704248D0 (sv) Medical use
DE3581699D1 (de) Bis-dimethoxymethyl(trimethoxybenzyl)isochinolinium-salze, ihre herstellung und diese enthaltende pharmazeutische zusammensetzungen.
UA34416C2 (uk) Похідні хроману, активні стосовно 5-нт рецептора, спосіб їх одержання та проміжні сполуки
PT99864A (pt) Processo para a preparacao de novas composicoes farmaceuticas contendo antagonistas de receptor de quisqualato
ES2052028T3 (es) Un metodo para preparar compuestos diarilicos anti-ateroscleroticos.
DE69501359D1 (de) Verwendung von Phosphatdiestern zur Behandlung von Erkrankungen der Retina
FR2717812B1 (fr) Indeno[1,2-e]pyrazine-4-ones, leur préparation et les médicaments les contenant.
MY103790A (en) Novel compound for the treatment of several bone affecting diseases
IL112999A0 (en) Crystalline salts of 2,3,4,5- tetrahydro -1h-3-benzazepine compounds, their preparation and pharmaceutical compositions containing them
SE8903529D0 (sv) Medical use
LV10607A (lv) Jauni bicikliski aminoaizvietoti savienojumi
BR9610175A (pt) Composto processo de preparação do composto composição farmacêutica e utilização do composto
HU9503099D0 (en) New piperazinyl-alkylthio-pyrimidine derivatives, pharmaceutical compositions containing them, and process for producing the active components
BR9306870A (pt) Derivados farmacologicamente ativos de (aminometila terciária) - benzenometanol
ES483286A1 (es) Un procedimiento para la preparacion de nuevas dibenzo (a,d)ciclohepten-5,10-iminas sustituidas
GB2004550A (en) Dibenzocycloocten-imines
GR3024854T3 (en) Drugs for preventing the development of tolerance during treatment with benzodiazepine-receptor-binding substances.
TW362097B (en) 3-Phenyl-1, 4-dialkyl-1,2,4-triazolium salts and their use as antidepressants
BR9812862A (pt) Composto, formulação farmacêutica, e, processo para a preparação de um composto
MX9601659A (es) Antagonistas del receptor de adhesion, procedimiento para prepararlos, composiciones farmaceuticas que los contienen y su empleo para preparar medicamentos y combatir enfermedades.
IT1246790B (it) Composizioni farmaceutiche per il trattamento del morbo di parkinson

Legal Events

Date Code Title Description
BB1A Laying open of patent application

Effective date: 19921021

FG3A Patent granted, date of granting

Effective date: 19990301

MM3A Annulment or lapse

Free format text: LAPSE DUE TO NON-PAYMENT OF FEES

Effective date: 20000930